PHEP Phase - 2 (Epi)

What is the CFDA# for this grant?

• 93.354 Public Health Emergency Response: Cooperative Agreement for Emergency Response: Public Health Crisis Response. 

• Subrecipients shall comply with the requirements applicable to the federal program. This includes  OMB Circular A-133 and/or Uniform Grant Guidance.

How much is this grant for?

• $2,433,600.00.

Who is this grant for?

• Specific Local Public Health Agencies that conduct epidemiological navigation and contact tracing.

What is it for?

• COVID-19 navigation and contact tracing.

What is the funding year? 

• We have received Federal approval for the PHEP No Cost Extension (no additional funds will be added to the POs) and will be extending the terms on the POs that have funds remaining from 2021 to 2022.

  • • March 16*, 2020 - March 15th, 2022. 

      • *This funding can backdate to January 20, 2020.

What are allowable costs? 

• CDC has determined that, as part of Components A and B activities allowable for the COVID-19 response, jurisdictions may use discretion to allocate this funding for their highest priority response needs in the following categories, consistent with applicable grant regulations and this guidance. With prior approval from CDC, reimbursement may be allowed for pre-award costs incurred on or after January 20, 2020, for certain public health expenses related to surveillance, epidemiology, laboratory capacity, infection control, mitigation, communications, and other preparedness and response activities associated with COVID-19 response activities and otherwise allowable under this guidance. 

  • • Domain 1: Incident Management for Early Crisis Response.

      • Emergency Operations and Coordination.

      • Responder Safety and Health.

      • Identification of Vulnerable Populations.

    • Domain 2: Jurisdictional Recovery.

      • Jurisdictional Recovery.

    • Domain 3: Information Management.

      • Information Sharing.

      • Emergency Public Information and Warning and Risk Communication.

    • Domain 4: Countermeasures and Mitigation.

      • Nonpharmaceutical Interventions.

      • Quarantine and Isolation Support.

      • Distribution and Use of Medical Materiel.

    • Domain 5: Surge Management.

      • Surge Staffing.

      • Public Health Coordination with Healthcare Systems.

      • Infection Control.

    • Domain 6: Biosurveillance.

      • Public Health Surveillance and Real-time Reporting.

      • Public Health Laboratory Testing, Equipment, Supplies, and Shipping.

      • Data Management.

    • Alteration or renovation of non-federal facilities that directly support activities in these six domains are allowable activities, subject to prior approval from CDC. More details about allowable activities are provided in Appendix 2.

What are unallowable costs? 

• Research.

• Clinical care except as provided above in connection with Domain 4 activities.

• Publicity and propaganda (lobbying).

• All unallowable costs cited in CDC-RFA-TP18-1802 remain in effect, unless specifically amended in this guidance, in accordance with 45 CFR Part 75 – Uniform Administrative Requirements, Cost Principles, And Audit Requirements for HHS Awards.